Last reviewed · How we verify

NCT05456464

Fatigue and Sleep Quality in Multiple Sclerosis Patients

Completed NA Last updated 31 August 2023
What this trial tests

NA trial testing Reiki in Multiple Sclerosis in 60 participants. Completed in 30 September 2022.

Timeline
1 June 2022
Primary endpoint
8 August 2022
30 September 2022

Quick facts

Lead sponsorIstanbul Sabahattin Zaim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date1 June 2022
Primary completion8 August 2022
Estimated completion30 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Sabahattin Zaim University

Who can join

Adults 18 to 80, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned to examine the effect of reiki application on fatigue and sleep quality in patients with multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Reiki

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Istanbul Sabahattin Zaim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05456464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing